Smith Lemli Opitz Sydrome Support Agencies

Find all needed information about Smith Lemli Opitz Sydrome Support Agencies. Below you can see links where you can find everything you want to know about Smith Lemli Opitz Sydrome Support Agencies.


Smith-Lemli-Opitz syndrome - Genetics Home Reference - NIH

    https://ghr.nlm.nih.gov/condition/smith-lemli-opitz-syndrome
    Oct 29, 2019 · Smith-Lemli-Opitz syndrome is a developmental disorder that affects many parts of the body. This condition is characterized by distinctive facial features, small head size (microcephaly), intellectual disability or learning problems, and behavioral problems.

The Official Smith-Lemli-Opitz RSH Foundation Website

    https://www.smithlemliopitz.org/
    Families and friends of individuals with Smith-Lemli-Opitz Syndrome will gather for the SLO Family Medical Conference June 27 – 29, 2019. About the Foundation: Smith-Lemli-Opitz RSH Foundation is a non-profit organization dedicated to supporting families, individuals and professionals dealing with Smith-Lemli-Opitz syndrome.

Smith-Lemli-Opitz syndrome Genetic and Rare Diseases ...

    https://rarediseases.info.nih.gov/diseases/5683/smith-lemli-opitz-syndrome
    158 rows · Mar 13, 2013 · Smith-Lemli-Opitz syndrome is a developmental disorder characterized by …

Smith-Lemli-Opitz Syndrome Treatment & Management: Medical ...

    https://emedicine.medscape.com/article/949125-treatment
    Aug 09, 2019 · Smith-Lemli-Opitz syndrome (SLOS) is a multiple congenital anomalies (MCA)/mental retardation (MR) syndrome caused by a defect in cholesterol synthesis. Smith-Lemli-Opitz syndrome is an autosomal recessive genetic condition caused by deficiency of the enzyme 3 beta-hydroxysterol-delta 7-reductase (7-dehydrocholesterol-delta 7-reductase [DHCR7...

Smith-Lemli-Opitz-syndrome

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491301/
    Smith-Lemli-Opitz syndrome is an autosomal recessively inherited disorder. A severe defect in cholesterol biosynthesis has been identified leading to abnormally low plasma cholesterol levels and elevated levels of the cholesterol precursor 7-dehydrocholesterol, the result of deficiency of 7-dehydrocholesterol reductase.

Smith-Lemli-Opitz Syndrome

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366105/
    Smith-Lemli-Opitz syndrome (SLOS) is a multiple congenital malformation syndrome that was first described by Smith, Lemli and Opitz in 1964 ().Many hundreds of SLOS cases have been reported since that time, leading to the recognition of SLOS as a relatively commonly cause of malformation syndrome.

The Smith-Lemli-Opitz syndrome Journal of Medical Genetics

    https://jmg.bmj.com/content/37/5/321
    May 01, 2000 · History. The Smith-Lemli-Opitz syndrome was first described in 1964 by the late David Smith, the Belgian paediatrician Luc Lemli, and John Opitz1 in a report of three patients who had in common a distinctive facial appearance, microcephaly, broad alveolar ridges, hypospadias, a characteristic dermatoglyphic pattern, severe feeding disorder, and global developmental delay.Cited by: 466



Need to find Smith Lemli Opitz Sydrome Support Agencies information?

To find needed information please read the text beloow. If you need to know more you can click on the links to visit sites with more detailed data.

Related Support Info